Jason T Goodrich, Age 51332 Rolling Knolls Way, Bridgewater, NJ 08807
Jason Goodrich Phones & Addresses
Bridgewater, NJ
3 Pauline Ct, Wallingford, CT 06492 (203) 715-4954
Shenandoah, PA
71 Scott St, Meriden, CT 06450 (203) 639-0073
71 Scott St #205, Meriden, CT 06450 (203) 639-0073
Middletown, CT
Mentions for Jason T Goodrich
Publications & IP owners
Us Patents
O-Derivatized Nocathiacin Derivatives
US Patent:
7022667, Apr 4, 2006
Filed:
Jul 3, 2002
Appl. No.:
10/189710
Inventors:
Thomas W. Hudyma - Durham CT, US
Xiaofan Zheng - Cheshire CT, US
B. Narasimhulu Naidu - Durham CT, US
Margaret E. Sorenson - Meriden CT, US
Alicia Regueiro-Ren - Middletown CT, US
Timothy P. Connolly - Middletown CT, US
John D. Matiskella - Wallingford CT, US
Oak K. Kim - Cambridge MA, US
Yunhui Zhang - Glastonbury CT, US
Dane M. Springer - North Haven CT, US
Jason Goodrich - Meriden CT, US
Yasutsugu Ueda - Clinton CT, US
Joanne J. Bronson - Durham CT, US
Xiaofan Zheng - Cheshire CT, US
B. Narasimhulu Naidu - Durham CT, US
Margaret E. Sorenson - Meriden CT, US
Alicia Regueiro-Ren - Middletown CT, US
Timothy P. Connolly - Middletown CT, US
John D. Matiskella - Wallingford CT, US
Oak K. Kim - Cambridge MA, US
Yunhui Zhang - Glastonbury CT, US
Dane M. Springer - North Haven CT, US
Jason Goodrich - Meriden CT, US
Yasutsugu Ueda - Clinton CT, US
Joanne J. Bronson - Durham CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 38/16
US Classification:
514 8, 514 9, 530317
Abstract:
The present invention provides compounds of formula I having potent antibiotic activity, including activity towards Gram-positive bacteria and mycobacteria.
Hepatitis C Virus Inhibitors
US Patent:
7659270, Feb 9, 2010
Filed:
Aug 8, 2007
Appl. No.:
11/835485
Inventors:
Carol Bachand - Candiac, CA
Makonen Belema - North Haven CT, US
Daniel H. Deon - Brossard, CA
Andrew C. Good - Wallingford CT, US
Jason Goodrich - Meriden CT, US
Clint A. James - Longueuil, CA
Rico Lavoie - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Alain Martel - Delson, CA
Nicholas A. Meanwell - East Hampton CT, US
Van N. Nguyen - New Britain CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Lawrence B. Snyder - Killingworth CT, US
Denis R. St. Laurent - Newington CT, US
Fukang Yang - Madison CT, US
David R. Langley - Meriden CT, US
Lawrence G. Hamann - North Grafton MA, US
Makonen Belema - North Haven CT, US
Daniel H. Deon - Brossard, CA
Andrew C. Good - Wallingford CT, US
Jason Goodrich - Meriden CT, US
Clint A. James - Longueuil, CA
Rico Lavoie - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Alain Martel - Delson, CA
Nicholas A. Meanwell - East Hampton CT, US
Van N. Nguyen - New Britain CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Lawrence B. Snyder - Killingworth CT, US
Denis R. St. Laurent - Newington CT, US
Fukang Yang - Madison CT, US
David R. Langley - Meriden CT, US
Lawrence G. Hamann - North Grafton MA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/4178
A61K 31/4196
A61K 31/4245
A61K 31/426
A61K 31/4353
A61K 31/4427
C07D 213/02
C07D 295/00
C07D 277/02
C07D 249/08
C07D 241/02
C07D 239/02
A61K 31/4196
A61K 31/4245
A61K 31/426
A61K 31/4353
A61K 31/4427
C07D 213/02
C07D 295/00
C07D 277/02
C07D 249/08
C07D 241/02
C07D 239/02
US Classification:
5142358, 51425205, 51425505, 514256, 514292, 514326, 514333, 514341, 514364, 514365, 514383, 514397, 544124, 544238, 544333, 544405, 546210, 546256, 5462741, 548133, 548146, 5482652, 5483147
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Hepatitis C Virus Inhibitors
US Patent:
7704992, Apr 27, 2010
Filed:
Jan 23, 2009
Appl. No.:
12/358308
Inventors:
Carol Bachand - Candiac, CA
Makonen Belema - North Haven CT, US
Daniel H. Deon - Brossard, CA
Andrew C. Good - Wallingford CT, US
Jason Goodrich - Meriden CT, US
Clint A. James - Longueuil, CA
Rico Lavoie - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Alain Martel - Delson, CA
Nicholas A. Meanwell - East Hampton CT, US
Van N. Nguyen - Meriden CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Lawrence B. Snyder - Killingworth CT, US
Denis R. St. Laurent - Newington CT, US
Fukang Yang - Madison CT, US
David R. Langley - Meriden CT, US
Gan Wang - Wallingford CT, US
Lawrence G. Hamann - North Grafton MA, US
Makonen Belema - North Haven CT, US
Daniel H. Deon - Brossard, CA
Andrew C. Good - Wallingford CT, US
Jason Goodrich - Meriden CT, US
Clint A. James - Longueuil, CA
Rico Lavoie - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Alain Martel - Delson, CA
Nicholas A. Meanwell - East Hampton CT, US
Van N. Nguyen - Meriden CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Lawrence B. Snyder - Killingworth CT, US
Denis R. St. Laurent - Newington CT, US
Fukang Yang - Madison CT, US
David R. Langley - Meriden CT, US
Gan Wang - Wallingford CT, US
Lawrence G. Hamann - North Grafton MA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/55
A61K 31/4155
C07D 223/18
C07D 233/54
A61K 31/4155
C07D 223/18
C07D 233/54
US Classification:
514217, 514397, 540587, 5483114, 5483131
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Hepatitis C Virus Inhibitors
US Patent:
7741347, Jun 22, 2010
Filed:
May 14, 2008
Appl. No.:
12/120494
Inventors:
Carol Bachand - Candiac, CA
Makonen Belema - North Haven CT, US
Daniel H. Deon - Brossard, CA
Andrew C. Good - Wallingford CT, US
Jason Goodrich - Meriden CT, US
Lawrence G. Hamann - North Grafton MA, US
Clint A. James - Longueuil, CA
David R. Langley - Meriden CT, US
Rico Lavoie - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Alain Martel - Delson, CA
Nicholas A. Meanwell - East Hampton CT, US
Van N. Nguyen - Meriden CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Lawrence B. Snyder - Killingworth CT, US
Denis R. St. Laurent - Newington CT, US
Gan Wang - Wallingford CT, US
Fukang Yang - Madison CT, US
Makonen Belema - North Haven CT, US
Daniel H. Deon - Brossard, CA
Andrew C. Good - Wallingford CT, US
Jason Goodrich - Meriden CT, US
Lawrence G. Hamann - North Grafton MA, US
Clint A. James - Longueuil, CA
David R. Langley - Meriden CT, US
Rico Lavoie - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Alain Martel - Delson, CA
Nicholas A. Meanwell - East Hampton CT, US
Van N. Nguyen - Meriden CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Lawrence B. Snyder - Killingworth CT, US
Denis R. St. Laurent - Newington CT, US
Gan Wang - Wallingford CT, US
Fukang Yang - Madison CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/4196
A61K 31/4245
A61K 31/4164
C07D 271/10
C07D 249/08
A61K 31/4245
A61K 31/4164
C07D 271/10
C07D 249/08
US Classification:
514364, 514383, 514400, 548143, 5482694, 5483147
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Hepatitis C Virus Inhibitors
US Patent:
7745636, Jun 29, 2010
Filed:
Feb 12, 2008
Appl. No.:
12/029680
Inventors:
Carol Bachand - Candiac, CA
Makonen Belema - North Haven CT, US
Daniel H. Deon - Brossard, CA
Andrew C. Good - Wallingford CT, US
Jason Goodrich - Meriden CT, US
Clint A. James - Longueuil, CA
Rico Lavoie - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Alain Martel - Delson, CA
Nicholas A. Meanwell - East Hampton CT, US
Van N. Nguyen - Meriden CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Lawrence B. Snyder - Killingworth CT, US
Denis R. St. Laurent - Newington CT, US
Fukang Yang - Madison CT, US
David R. Langley - Meriden CT, US
Gan Wang - Wallingford CT, US
Lawrence G. Hamann - North Grafton MA, US
Makonen Belema - North Haven CT, US
Daniel H. Deon - Brossard, CA
Andrew C. Good - Wallingford CT, US
Jason Goodrich - Meriden CT, US
Clint A. James - Longueuil, CA
Rico Lavoie - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Alain Martel - Delson, CA
Nicholas A. Meanwell - East Hampton CT, US
Van N. Nguyen - Meriden CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Lawrence B. Snyder - Killingworth CT, US
Denis R. St. Laurent - Newington CT, US
Fukang Yang - Madison CT, US
David R. Langley - Meriden CT, US
Gan Wang - Wallingford CT, US
Lawrence G. Hamann - North Grafton MA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 233/02
A01N 43/50
A01N 43/50
US Classification:
5483001, 514396
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Hepatitis C Virus Inhibitors
US Patent:
7759495, Jul 20, 2010
Filed:
Aug 8, 2007
Appl. No.:
11/835524
Inventors:
Carol Bachand - Candiac, CA
Makonen Belema - North Haven CT, US
Daniel H. Deon - Brossard, CA
Andrew C. Good - Wallingford CT, US
Jason Goodrich - Meriden CT, US
Clint A. James - Longueuil, CA
Rico Lavoie - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Alain Martel - Delson, CA
Nicholas A. Meanwell - East Hampton CT, US
Van N. Nguyen - New Britain CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Lawrence B. Snyder - Killingworth CT, US
Denis R. St. Laurent - Newington CT, US
Fukang Yang - Madison CT, US
David R. Langley - Meriden CT, US
Lawrence G. Hamann - North Grafton MA, US
Makonen Belema - North Haven CT, US
Daniel H. Deon - Brossard, CA
Andrew C. Good - Wallingford CT, US
Jason Goodrich - Meriden CT, US
Clint A. James - Longueuil, CA
Rico Lavoie - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Alain Martel - Delson, CA
Nicholas A. Meanwell - East Hampton CT, US
Van N. Nguyen - New Britain CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Lawrence B. Snyder - Killingworth CT, US
Denis R. St. Laurent - Newington CT, US
Fukang Yang - Madison CT, US
David R. Langley - Meriden CT, US
Lawrence G. Hamann - North Grafton MA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 233/02
A01N 43/50
A01N 43/50
US Classification:
5483001, 514396
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Hepatitis C Virus Inhibitors
US Patent:
7906655, Mar 15, 2011
Filed:
Aug 5, 2009
Appl. No.:
12/536362
Inventors:
Makonen Belema - North Haven CT, US
Andrew C. Good - Wallingford CT, US
Jason Goodrich - Wallingford CT, US
Ramesh Kakarla - South Glastonbury CT, US
Guo Li - Wallingford CT, US
Omar D. Lopez - Wallingford CT, US
Van N. Nguyen - Meriden CT, US
Jayne Kapur - Houston TX, US
Yuping Qiu - Princeton Junction NJ, US
Jeffrey Lee Romine - Meriden CT, US
Denis R. St. Laurent - Newington CT, US
Michael Serrano-Wu - Belmont MA, US
Lawrence B. Snyder - Killingworth CT, US
Fukang Yang - Madison CT, US
Andrew C. Good - Wallingford CT, US
Jason Goodrich - Wallingford CT, US
Ramesh Kakarla - South Glastonbury CT, US
Guo Li - Wallingford CT, US
Omar D. Lopez - Wallingford CT, US
Van N. Nguyen - Meriden CT, US
Jayne Kapur - Houston TX, US
Yuping Qiu - Princeton Junction NJ, US
Jeffrey Lee Romine - Meriden CT, US
Denis R. St. Laurent - Newington CT, US
Michael Serrano-Wu - Belmont MA, US
Lawrence B. Snyder - Killingworth CT, US
Fukang Yang - Madison CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 403/14
C07D 217/08
C07D 211/32
C07D 239/04
C07D 413/14
A61K 31/47
A61K 31/497
A61K 31/445
A61K 31/5355
A01N 43/60
C07D 217/08
C07D 211/32
C07D 239/04
C07D 413/14
A61K 31/47
A61K 31/497
A61K 31/445
A61K 31/5355
A01N 43/60
US Classification:
5483117, 546149, 546199, 544370, 544139, 514309, 51425406, 514322, 514394, 5142345
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Hepatitis C Virus Inhibitors
US Patent:
8093243, Jan 10, 2012
Filed:
Feb 10, 2009
Appl. No.:
12/368465
Inventors:
Carol Bachand - Candiac, CA
Makonen Belema - North Haven CT, US
Daniel H. Deon - Brossard, CA
Andrew C. Good - Wallingford CT, US
Jason Goodrich - Meriden CT, US
Clint A. James - Longueuil, CA
Rico Lavoie - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Alain Martel - Delson, CA
Nicholas A. Meanwell - East Hampton CT, US
Van N. Nguyen - Meriden CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Lawrence B. Snyder - Killingworth CT, US
Denis R. St. Laurent - Newington CT, US
Fukang Yang - Madison CT, US
David R. Langley - Meriden CT, US
Gan Wang - Wallingford CT, US
Lawrence G. Hamann - North Grafton MA, US
Makonen Belema - North Haven CT, US
Daniel H. Deon - Brossard, CA
Andrew C. Good - Wallingford CT, US
Jason Goodrich - Meriden CT, US
Clint A. James - Longueuil, CA
Rico Lavoie - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Alain Martel - Delson, CA
Nicholas A. Meanwell - East Hampton CT, US
Van N. Nguyen - Meriden CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Lawrence B. Snyder - Killingworth CT, US
Denis R. St. Laurent - Newington CT, US
Fukang Yang - Madison CT, US
David R. Langley - Meriden CT, US
Gan Wang - Wallingford CT, US
Lawrence G. Hamann - North Grafton MA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/535
C07D 413/00
C07D 413/00
US Classification:
5142345, 544119
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Amazon
Paul And The Apocalyptic Imagination
Author:
Ben C. Blackwell, John K. Goodrich, Jason Maston
Publisher:
Fortress Press
Binding:
Paperback
Pages:
488
ISBN #:
1451482086
EAN Code:
9781451482089
Since the mid-twentieth century, apocalyptic thought has been championed as a central category for understanding the New Testament writings and the letters of Paul above all. But "apocalyptic" has meant different things to different scholars. Even the assertion of an "apocalyptic Paul" has been cont...
Reading Romans In Context: Paul And Second Temple Judaism
Publisher:
Zondervan
Binding:
Paperback
Pages:
192
ISBN #:
0310517958
EAN Code:
9780310517955
Readers of Paul today are more than ever aware of the importance of interpreting Paul’s letters in their Jewish context. In Reading Romans in Context a team of Pauline scholars go beyond a general introduction that surveys historical events and theological themes and explore Paul’s letter to the Rom...
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.